OncoFactory is a science-driven biotech whose mission is to provide pharmaceutical and biotechnology companies with innovative in vivo services to accompany their preclinical programs in oncolgy (drugs, targeted therapy and immunotherapy). OncoFactory offers an innovative technological platform with a chore process of replication of patient tumors in an in vivo organism, the avian embryo (AVI-PDX TM). OncoFactory brings solutions for a panel of preclinical studies, from drug discovery to the evaluation of monotherapies and combinations of therapies.